Loading...
Pipeline Trends December 2016
Cummins, Timothy
Cummins, Timothy
Citations
Altmetric:
Authors
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Report
Publication Date
2016-12-08
Subject Area
Collections
Files
Embargo Expiration Date
Link to Full Text
Abstract
Pipeline Trends is produced by UMass Medical School’s Clinical Pharmacy Services division and is distributed at least once a year. This edition provides a comprehensive overview of:
- Promising New Agents: Abaloparatide, Cannabidiol, Dupilumab, and others
- Projected Generic Entry: Strattera®, Tamiflu®, Truvada®, Zetia®, and others
- Investigational Indications: Cabozantinib and Tofacitinib
- FDA Updates
- Industry Trends
Source
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.13028/br4g-d279
Permanent Link to this Item
PubMed ID
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
© University of Massachusetts Medical School 2016